Tuesday, October 29, 2024
26.1 C
Delhi

Eli Lilly obtains nod to introduce weight-loss drugs in Hong Kong


(Reuters) – Eli Lilly anticipates to start providing its weight-loss drugs in Hong Kong as early as completion of this yr, Bloomberg News reported on Sunday.

The enterprise has really gotten the Hong Kong federal authorities authorization to market its tirzepatide photographs– branded as Mounjaro– in a gadget referred to as Kwikpen for each long-lasting weight administration and type 2 diabetes mellitus, Eli Lilly knowledgeable Bloomberg in a declaration.

(Reporting by Jahnavi Nidumolu in Bengaluru)



Source link

Hot this week

Women are discovering it more difficult to make ends fulfill

As the added to the united state governmental...

United States capitalist revitalizes debatable Revolut share deal after FCA drawback

Monday 28 October 2024 4:18 pm A United...

Stocks making most important relocations noontime: MRNA, HOOD, NIO

Check out the corporations making headings in noontime...

apple iphone’s nearly all of anticipated perform is in the end launched

Apple has truly in the end launched the...

Apple iMac with M4 chip launched, begins at $1,299

Apple on Monday launched an updated iMac with...

Topics

Related Articles

Popular Categories

spot_imgspot_img